EXECUTIVE OVERVIEW
Long-term care facilities, including the pharmacies who supply them, and the healthcare providers who service their patients, stand squarely in the crosshairs of federal and state regulators who expect flawless stewardship of controlled substances. The Drug Enforcement Administration (DEA) requires “readily retrievable” records regarding the receipt and disposition of every Schedule II–V dose, that the facility have anti-diversion protocols, and that the facility provide notice to regulators immediately upon detection of diversion. The Centers for Medicare & Medicaid Services (CMS) overlays its own pharmacy-services mandate, obligating consultant pharmacists to maintain an unbroken chain of documentation from receipt to disposition of controlled substances, reconcile inventories regularly, and prove to surveyors that every dose is either administered to the resident or appropriately destroyed. The HHS Office of Inspector General’s 2024 compliance guidance raises the bar further by declaring that organizations—not just individual clinicians—will be held accountable when diversion takes place.
State laws often impose additional requirements to prevent diversion and uphold accountability. West Virginia, for example, demands two-nurse verification for all counts, administrations, and disposals, monthly log reviews by the director of nursing, quarterly board reporting, and parallel notification to multiple state agencies the moment a dose is deemed missing. Ohio insists on blind, dual-signed reconciliation at every change of shift, three-year on-site document retention, positive identification on every transaction, and immediate escalation of any variance. Across jurisdictions, the failure to meet these intertwined expectations at the federal and state levels, can trigger multimillion-dollar DEA settlements, CMS civil money penalties, license suspension, and OIGimposed Corporate Integrity Agreements. In short, controlled-substance management has become a make-or-break enterprise-risk issue for skilled nursing and assisted living providers.
THE COMPLIANCE GAP
Notwithstanding the risks and demands of the current regulatory climate, many facilities continue to rely upon outdated paper narcotic logbooks or fragmented electronic spreadsheets that were never engineered to satisfy modern regulatory scrutiny. Handwritten entries go missing or prove illegible, post-dated alterations raise “red flags” for surveyors triggering increased scrutiny, and shift counts consume valuable nursing hours while still allowing discrepancies to linger undiscovered for days or weeks. When a shortfall finally surfaces, the facility is already out of time: the DEA’s one-business-day reporting clock has expired, state hotlines were never notified, and management faces accusations that “effective controls” were never in place. Meanwhile, overstocked or expired medications are quietly wasted, contributing to an estimated $125 million in unused medications destroyed each year in U.S. nursing homes—expenditures ultimately borne by Medicare, Medicaid, and facility operating budgets. The cumulative impact is stark: heightened liability, potential exclusion from federal programs, lost staff productivity, and needless financial leakage.
SURECOUNT: PURPOSE-BUILT TECHNOLOGY
SureCount was designed from the ground up to close this gap and meet these modern-day challenges, by embedding statutory and regulatory requirements directly into daily workflow. The software replaces every paper log with a real-time, immutable electronic narcotic book that captures each receipt, administration, waste, and return the moment it occurs. Because every transaction is time-stamped, user-authenticated, and tamper-evident, the system expeditiously delivers the “readily retrievable” record set that DEA investigators demand and CMS surveyors expect to review on site.
SureCount allows a facility to maintain at its fingertip a perpetual inventory regarding all controlled substances, so within moments, providers are aware of just how much medication there is in-hand, and every dose is accounted for. The software detects anomalies and variances indicative of unlawful diversion permitting immediate investigation and internal resolution of the variance and appropriate reporting to DEA when required.
Shift change becomes a simple, guided workflow. The outgoing and incoming licensed professionals perform a blind physical count; SureCount reconciles that count against expected inventory and will not accept their electronic signatures until both parties attest to the result. If a variance appears, the system escalates the alert to designated managers, furnishing the data necessary to investigate quickly and, if warranted, file Form 106 and state loss reports within hours rather than weeks.
When a medication is discontinued, refused, or partially administered, SureCount automatically prompts for witnessed disposal, capturing the drug name, quantity, method of destruction, and identities of both licensed witnesses before the record can be closed. That process fulfills DEA disposal regulations, CMS pharmacy guidance, and corresponding state rules in a single step. Consultant pharmacists and directors of nursing can generate monthly, quarterly, or ad-hoc audit reports with a click—eliminating hours of manual reconciliation.
Because SureCount integrates through HL7 or ADT feeds with leading pharmacy, eMAR, and automated dispensing cabinet platforms, its inventory counts remain synchronized with physician orders and actual bedside administrations. Fragmented data silos disappear, and the facility gains a single source of truth for every controlled dose. Unusual PRN patterns, repeated waste entries by the same clinician, or after-hours cabinet access outside normal parameters trigger configurable real-time alerts, empowering leadership to intervene before a situation escalates into a diversion incident.
RISK MITIGATION AND RETURN ON INVESTMENT
The operational impact is immediate and tangible. Facilities that adopt SureCount typically report cutting nurse counting time in half, freeing clinical staff to focus on resident care without sacrificing accountability. Automated refill thresholds and short-cycle dispensing support reduce overstock, curb expiration waste, and enable participation in credit or drug-repository programs, converting what was once sunk cost into recaptured value.
From a legal and compliance perspective, SureCount functions as a facility insurance policy. Comprehensive, tamper-proof logs demonstrate proactive good-faith efforts to curb diversion, a factor which regulators consistently weigh when deciding between corrective action plans and punitive fines. Should diversion occur despite best efforts, the facility is able to demonstrate that it detected the anomaly quickly, notified authorities within required timeframes, and produced a complete chain-of-custody narrative—dramatically reducing exposure to damaging settlements.
Financial upside extends beyond avoiding fines and lawsuits. Preventing even a single major diversion event, which can cost millions of dollars in investigation fees, resident litigation, and reputational harm, greatly offsets the cost of SureCount deployment. Meanwhile, incremental savings from reduced waste and reclaimed staff time accrue every day.
CONCLUSION
Regulatory scrutiny of controlled-substance handling has never been more intense, nor the consequences of noncompliance more severe. SureCount transforms controlled substance management from a manual, error-prone chore into a seamless, fully compliant, and transparent operation.